Walicke joins Oxigene
July 31, 2007 11:36 AM
E-mail|
|Comments
()|
Text size
–
+
Oxigene Inc., a Waltham biopharmaceutical company, today said it has named Patricia Walicke as its chief medical officer.
Oxigene focuses on developing small molecule therapeutics to treat cancer and eye diseases.
Most recently, Walicke served as vice president of clinical and regulatory affairs at Avidia Inc., a subsidiary of Amgen Inc., a California-based biotechnology company, Oxigene said.
(By Chris Reidy, Globe staff)
Comment
Permalink
E-mail
